Mr. Terry Booth reports

AURORA CANNABIS STRENGTHENS LEADERSHIP TEAM ADDING CHIEF PRODUCT OFFICER AND CHIEF INTEGRATION OFFICER

Aurora Cannabis Inc. has provided an update. Effective immediately, Dr. Shane Morris, formerly senior vice-president of product development and regulatory affairs, has been promoted to chief product officer, and Andre Jerome, formerly senior vice-president of business integrations, has been promoted to chief integration officer.

"Aurora is committed to maintaining its global leadership position in the cannabis industry and we have built a strong team that will drive the future growth and strategic development of the business," said Terry Booth, chief executive officer. "Shane has played a critical role in overseeing Aurora's product development and regulatory initiatives, which have resulted in the successful launch of many novel product forms and the successful management of our many site licences. As we enter the next phase of consumer legalization in Canada and global expansion, Shane will play a critical role in ensuring we continue to have the right mix of products in all markets that will resonate with both our patients and consumers."

Mr. Booth added: "With diverse business integration experience, Andre has played a critical role in the successful integration of our global assets and subsequently ensuring we continue to drive strong value from these transactions for our investors. Andre's contributions have allowed us to strategically assemble a portfolio of high-quality assets that together are uniquely positioned to continue to lead the global cannabis industry."

Chief product officer

Dr. Morris joined Aurora in January, 2018, to lead the company's product development and regulatory affairs initiatives. Committed to science-based, consumer-focused innovation, Dr. Morris has led the development, regulatory oversight and market introduction for several of the company's innovative cannabis products, including Aurora's Oral Mist, Oral Dissolve Strips and Aurora Cloud, the first-ever vape-ready oil cartridge to be introduced under Health Canada regulations. In his new role, Dr. Morris will be responsible for the company's product development for the Canadian and international markets. Dr. Morris holds a PhD in plant science and policy from the National University of Ireland (NUI), Galway, and a BSc in biology and mathematics from NUI, Maynooth.

Chief integration officer

Mr. Jerome joined Aurora in February, 2018, through the acquisition of H2 Biopharma, which now operates as the company's Aurora Eau facility in Lachute, Que. Initially responsible for the integration of Aurora's acquisitions as well as the identification of synergies across existing subsidiaries and joint venture partners, Mr. Jerome's role has expanded over the last 18 months to include global security, health, safety and environment, and oversight for a number of subsidiaries. As chief integration officer, Mr. Jerome will oversee all current and future integrations with a focus on value generation to support the company's expansion strategy. Mr. Jerome has led the successful integration of many of Aurora's largest business assets including CanniMed Therapeutics, MedReleaf, Whistler Cannabis and Anandia Laboratories.

About Aurora Cannabis Inc.

Headquartered in Edmonton, Alta., Canada, with financed capacity in excess of 625,000 kilograms per annum and sales and operations in 25 countries across five continents, Aurora is one of the world's largest and leading cannabis companies.

We seek Safe Harbor.